Eight-Year Trends in the Use of Opioids, Other Analgesics, and Psychotropic Medications Among Institutionalized Older People in Finland

Journal of the American Medical Directors Association

Volumn 16, Issue 11, 2015, Pages 973-978

  Pitkala, Kaisu H ^a   Juola, Anna Liisa ^a,b   Hosia, Helka ^a,c   Teramura Gronblad, Mariko ^a   Soini, Helena ^d   Savikko, Niina ^a,e   Bell, J Simon ^f,g,h  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Health Services   (Finland)

^c Tapiola Health Centre   (Finland)

^d Social Services Department   (Finland)

^e Elderly care   (Finland)

^f MONASH UNIVERSITY   (Australia)

^g UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Analgesics; Nursing home; Opioids; Psychotropics; Sedative load

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; OPIATE; PSYCHOTROPIC AGENT; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; ASSISTED LIVING FACILITY; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMENTIA; ELDERLY CARE; FEMALE; FINLAND; HOME ENVIRONMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; NURSING HOME PATIENT; PREVALENCE; RESIDENTIAL HOME; VERY ELDERLY; DRUG THERAPY; DRUG UTILIZATION REVIEW; STATISTICS; TRENDS;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ASSISTED LIVING FACILITIES; CROSS-SECTIONAL STUDIES; DRUG THERAPY; DRUG UTILIZATION REVIEW; FEMALE; FINLAND; HUMANS; MALE; NURSING HOMES; PSYCHOTROPIC DRUGS; STATISTICS AS TOPIC;

EID: 84947870590     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.06.009     Document Type: Article

References (46)

1. Teno J.M., Weitzen S., Wetle T., Mor V. Persistent pain in nursing home residents. JAMA 2001, 285:2081.
2. Won A.B., Lapane K.L., Vallow S., et al. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc 2004, 52:867-874.
3. Lukas A., Mayer B., Fialová D., et al. Treatment of pain in European nursing homes: Results from the Services and Health for Elderly in Long TERm Care (SHELTER) study. J Am Med Dir Assoc 2013, 14:821-831.
4. Bernabei R., Gambassi G., Lapane K., et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998, 279:1877-1882.
5. de Souto Barreto P., Lapeyre-Mestre M., Vellas B., Rolland Y. Potential underuse of analgesics for recognized pain in nursing home residents with dementia: A cross-sectional study. Pain 2013, 154:2427-2431.
6. Tosato M., Lukas A., van der Roest H.G., et al. Association of pain with behavioral and psychiatric symptoms among nursing home residents with cognitive impairment: Results from the SHELTER study. Pain 2012, 153:305-310.
7. Husebo B.S., Ballard C., Sandvik R., et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: Cluster randomised clinical trial. BMJ 2011, 343:d4065.
8. Won A., Lapane K.L., Vallow S., et al. Long-term effects of analgesics in a population of elderly nursing home residents with persistent nonmalignant pain. J Gerontol A Biol Sci Med Sci 2006, 61:165-169.
9. Pergolizzi J., Böger R.H., Budd K., et al. Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008, 8:287-313.
10. Chou R., Fanciullo G.J., Fine P.G., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10:113-130.
11. Barber J.B., Gibson S.J. Treatment of chronic non-malignant pain in the elderly: Safety considerations. Drug Saf 2009, 32:457-474.
12. Abdulla A., Adams N., Bone M., et al. Guidance on the management of pain in older people. Age Ageing 2013, 42:i1-i57.
13. Kress H.G. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain 2009, 13:219-230.
14. Ballantyne J.C. Chronic opioid therapy and its utility in different populations. Pain 2012, 153:2303-2304.
15. Sullivan M.D., Ballantyne J.C. What are we treating with long-term opioid therapy?. Arch Intern Med 2012, 172:433-434.
16. Solomon D.H., Rassen J.A., Glynn R.J., et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med 2010, 170:1979-1986.
17. Ballantyne J.C. "Safe and effective when used as directed": The case of chronic use of opioid analgesics. J Med Toxicol 2012, 8:417-423.
18. Rolita L., Spegman A., Tang X., Cronstein B.N. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc 2013, 61:335-340.
19. Söderberg K.C., Laflamme L., Möller J. Newly initiated opioid treatment and the risk of fall-related injuries. CNS Drugs 2013, 27:155-161.
20. Makris U.E., Abrams R.C., Gurland B., Reid M.C. Management of persistent pain in the older patient: A clinical review. JAMA 2014, 312:825-836.
21. Chou R., Turner J.A., Devine E.B., et al. The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med 2015, 162:276-286.
22. Wright R.M., Roumani Y.F., Boudreau R., et al. Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: Findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2009, 57:243-250.
23. Puustinen J., Nurminen J., Löppönen M., et al. Use of CNS medications and cognitive decline in the aged: A longitudinal population-based study. BMC Geriatr 2011, 11:70.
24. Laurila J.V., Laakkonen M.L., Tilvis R.S., Pitkala K.H. Predisposing and precipitating factors for delirium in a frail geriatric population. J Psychosom Res 2008, 65:249-254.
25. Sullivan M.D., Edlund M.J., Fan M.Y., et al. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: The TROUP study. Pain 2008, 138:440-449.
26. Bell J.S., Klaukka T., Ahonen J., Hartikainen S. National utilization of transdermal fentanyl among community-dwelling older people in Finland. Am J Geriatr Pharmacother 2009, 7:355-361.
27. Atluri S., Sudarshan G., Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician 2014, 17:E119-E128.
28. Onder G., Liperoti R., Foebel A., et al. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: Results from the SHELTER study. J Am Med Dir Assoc 2013, 14:450.e7-450.e12.
29. Hosia-Randell H., Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 2005, 22:793-800.
30. Pitkälä K.H., Juola A.L., Kautiainen H., et al. Education to reduce potentially harmful medication use among residents of assisted living facilities: A randomized controlled trial. J Am Med Dir Assoc 2014, 15:892-898.
31. Hartikainen S., Lönnroos E., Louhivuori K. Medication as a risk factor for falls: Critical systematic review. J Gerontol A Biol Sci Med Sci 2007, 62:1172-1181.
32. Paterniti S., Dufouil C., Alpérovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: The Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002, 22:285-293.
33. Ballard C., Corbett A. Management of neuropsychiatric symptoms in people with dementia. CNS Drugs 2010, 24:729-739.
34. Schneider L.S., Dagerman K.S., Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294:1934-1943.
35. Wang P.S., Schneeweiss S., Avorn J., et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353:2335-2341.
36. Bell J.S., Taipale H.T., Soini H., Pitkälä K.H. Sedative load among long-term care facility residents with and without dementia: A cross-sectional study. Clin Drug Investig 2010, 30:63-70.
37. Suominen M., Sandelin E., Soini H., Pitkälä K. How do nurses evaluate malnutrition with their patients?. Eur J Clin Nutr 2009, 63:292-296.
38. Muurinen S.M., Savikko N.M., Soini H.H., et al. Nutrition and psychological well-being among long-term care residents with dementia. J Nutr Health Aging 2015, 19:178-182.
39. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Classification System. ATC/DDD Index 2012. Available at: Accessed February 12, 2015. http://www.whocc.no/atc_ddd_index/.
40. Taipale H.T., Hartikainen S., Bell J.S. A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties. Am J Geriatr Pharmacother 2010, 8:460-471.
41. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
42. Guigoz Y., Lauque S., Vellas B.J. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002, 18:737-757.
43. Beers Criteria Update Panel. American Geriatrics Society updated criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012, 60:616-631. American Geriatrics Society.
44. Sink K.M., Holden K.F., Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. JAMA 2005, 293:596-608.
45. Babiy M., Stubblefield M.D., Herklotz M., Hand M. Asterixis related to gabapentin as a cause of falls. Am J Phys Med Rehabil 2005, 84:136-140.
46. Spence D. Bad medicine: Gabapentin and pregabalin. BMJ 2013, 347:f6747.